Trial intelligence / Profile preview

Amoxicillin for lower respiratory tract infection in children in primary care

2015-002455-97Phase 4Completed

Sponsor
University of Southampton
Start
Jul 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of amoxicillin in pulmonary infection and acute respiratory illness (ARI) (2 arms), sponsored by University of Southampton. Primary endpoint: Mean duration of symptoms rated moderately bad or worse. Started Jul 2020; status: completed.

02

Drugs

amoxicillin
03

Conditions

pulmonary infectionacute respiratory illness (ARI)

Beyond the preview

Go deeper on 2015-002455-97.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-002455-97.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call